Electromagnetic Therapy for Metastatic Thyroid Cancer
Cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well-tolerated and may have biological efficacy in patients with advanced Thyroid Cancer.
Thyroid cancer that has metastasized is almost impossible to treat. If fact, I don’t believe that conventional oncology has any real therapies for it. Stable disease lasting for a bit less than three years may not look like much but keep in mind that this therapy comes with no NCI grade 2,3 or 4 side effects.
The challenge for the cancer patient is to find a practitioner of this admittedly very alternative cancer therapy.
I am both a cancer survivor and cancer coach. While my cancer is completely different from thyroid cancer both cancers share the fact that conventional oncology considers them to be “incurable.”
I work with cancer patients to identify all possible treatment options for all types of cancer at any stage.
Click now to go to the Complete Cancer Coaching Products store.
Scroll down the page to ask a question or make a comment.
Thank you,
David Emerson
- Cancer Survivor
- Cancer Coach
- Director PeopleBeatingCancer
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.
“Purpose-Because in vitro studies suggest that low levels of electromagnetic fields may modify cancer cell growth, we hypothesized that systemic delivery of a combination of tumor-specific frequencies may have a therapeutic effect. We undertook this study to identify tumor-specific frequencies and test the feasibility of administering such frequencies to patients with advanced cancer.
Patients and methods
We examined patients with various types of cancer using a noninvasive biofeedback method to identify tumor-specific frequencies. We offered compassionate treatment to some patients with advanced cancer and limited therapeutic options.
Results
We examined a total of 163 patients with a diagnosis of cancer and identified a total of 1524 frequencies ranging from 0.1 Hz to 114 kHz. Most frequencies (57–92%) were specific for a single tumor type. Compassionate treatment with tumor-specific frequencies was offered to 28 patients. Three patients experienced grade 1 fatigue during or immediately after treatment. There were no NCI grade 2, 3 or 4 toxicities.
Thirteen patients were evaluable for response:
- One patient with hormone-refractory breast cancer metastatic to the adrenal gland and bones had a complete response lasting 11 months.
- One patient with hormone-refractory breast cancer metastatic to liver and bones had a partial response lasting 13.5 months.
- Four patients had stable disease lasting for +34.1 months (thyroid cancer metastatic to lung), 5.1 months (non-small cell lung cancer), 4.1 months (pancreatic cancer metastatic to liver) and 4.0 months (leiomyosarcoma metastatic to liver).
Conclusion-Cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well tolerated and may have biological efficacy in patients with advanced cancer.